TELOS CORP

For the period ended Dec 31, 2025. Filed Mar 16, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 16, 2026

TLS$7.17+48.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

. Other Balance Sheet Components

OTHER BALANCE SHEET COMPONENTS

Table 8.1: Details of Other Current Assets
	As of December 31,
	2025	2024
(in thousands)
Inventories, net	$996	$1,783
Deferred costs	887	573
Receivables - other	529	210
Other	1,250	10
Other current assets	$3,662	$2,576

Table 8.2: Details of Other Assets
	As of December 31,
	2025	2024
(in thousands)
Investment (1)	$3,750	$3,000
Prepaid expenses and deferred commission – long-term portion	537	4,975
Restricted cash	140	139
Other	86	75
Other assets	$4,513	$8,189

(1) In March 2024, the Company made a $3.0 million investment in a privately-held company via a simple agreement for future equity ("SAFE"). During fiscal year 2024, the Company elected to apply the fair value option ("FVO") for its SAFE investment, as the Company believes the FVO best reflects the economics of the underlying transaction. In October 2025, the Company's SAFE investment was settled into 8,964,262 shares of Series A common stock at a settlement price of $0.42 per share, based on the valuation cap in the original agreement, resulting in 3.8% ownership with no significant influence over the privately-held company. Upon settlement of the SAFE in fiscal year 2025, the investment was remeasured to its fair value of $3.8 million, and a fair value adjustment of $0.8 million was recorded within "Other income" on the consolidated statements of operations. Effective October 2025, the SAFE investment was settled into equitable shares of the privately-held company's common stock. The investment does not have a readily determinable fair value and the Company elected the measurement alternative to value its investment. The fair value of this investment was based on non-marketable observable inputs, which represent Level 3 measurement within the fair value hierarchy. The investment was carried at cost less impairment, if any, and subsequently measured to fair value upon observable price changes in an orderly transaction for the identical or similar investments of the same issuer, with any gains or losses recorded within "Other income" on the consolidated statements of operations.

Table 8.3: Details of Accrued Liabilities
	As of December 31,
	2025	2024
(in thousands)
Accrued project expenses	$4,289	$3,238
Restructuring expenses accrual	1,451	37
Other	1,160	1,174
Accrued liabilities	$6,900	$4,449

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.